Institut National pour la Recherche Biomedicale

The Institut National pour la Recherche Biomedicale (INRB) is the national medical research organization of the Democratic Republic of the Congo.[1] The responsible ministry is the Ministry of Scientific Research and Technology.[2]

The INRB was founded in 1984,[2] and has been a World Health Organization collaborating centre since 2018.[3] The INRB and the World Health Organization have worked closely together in research into the effectiveness of the ring vaccination strategy in the 2018 Kivu Ebola outbreak.[4][5]

The INRB is based at Avenue de la Démocratie (formerly the Avenue des Huileries), BP 1197 in Kinshasa-Gombe, DRC.[6][7]

References
  1. "Institut National de Recherche Biomédicale — ERA-LEARN". www.era-learn.eu. Retrieved 2019-04-17.
  2. "A Baseline Study on Science and Technology and Higher Education in the SADC Region: Democratic Republic of Congo" (PDF). Southern African Regional Universities Association. Retrieved 2019-04-17.
  3. "ITM partner first WHO collaborating centre in the DRC". www.itg.be. 15 November 2018. Retrieved 2019-04-17.
  4. Mole, Beth (2019-04-16). "As Ebola outbreak rages, vaccine is 97.5% effective, protecting over 90K people". Ars Technica. Retrieved 2019-04-17.
  5. "Ebola Ring Vaccination Results 12 April 2019" (PDF). www.who.int. 12 April 2019. Retrieved 17 April 2019.
  6. Muyembe, J. J. (June 2012). "WORKSHOP ON HEALTH AND ECONOMIC IMPACT OF INFLUENZA" (PDF). www.who.int.
  7. Nakazawa, Yoshinori; Mauldin, Matthew R.; Emerson, Ginny L.; Reynolds, Mary G.; Lash, R. Ryan; Gao, Jinxin; Zhao, Hui; Li, Yu; Muyembe, Jean-Jacques (2015-04-22). "A phylogeographic investigation of African monkeypox". Viruses. 7 (4): 2168–2184. doi:10.3390/v7042168. ISSN 1999-4915. PMC 4411695. PMID 25912718.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.